Pharma Reimbursement & Market Access
Date: | 24-Mar-15 to 25-Mar-15 |
Location: | Boston Marriott Burlington / Boston / Massachusetts / United States |
Category: | Healthcare & Pharmaceuticals Conferences & Trade Fairs |
Patent expirations, the availability of generics and biosimilars have changed. This strategy meeting will cover the key topics that are the drivers behind the issues that we face.
Visitors
Attendees will
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer’s overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
*Anticipate the implementation of ICD-10 and the underlying effect on product access
*Analyze the current state of affairs: Post midterm elections in the exchange marketplace and the impact on drug positioning
*Determine your engagement model: The new look of pharma/ biopharma/payer relationship
*Understand when, where and how Comparative Effectiveness Research should be factored into a drug manufacturer’s overall market access strategy
*Learn how to predict shifts and corrections in policy from the Center for Medicare and Medicaid Services to maximize product placement
*Examine how to use HTA to create payer evidence: The role of postapproval programs
*Learn key concepts that public and private payers are looking for: Think like and ACO to build quality partnerships
*Examine the evolution of generics and biosimilars: How their impact will shift the markets- Can Pharma benefit
*Gain insight from managed care organizations: Their role as Pointof- Care and how their determinations affect your bottom line
*Anticipate the implementation of ICD-10 and the underlying effect on product access
*Analyze the current state of affairs: Post midterm elections in the exchange marketplace and the impact on drug positioning
*Determine your engagement model: The new look of pharma/ biopharma/payer relationship
Exhibitors
Your speakers:
- Andrew Storey
Abbvie
United States
VP
- Stacie Maass
American Pharmacist
United States
SVP Government Affairs
- Oved Amitay
Alnylam Pharma
United States
Vice President
...see the full speaker list on our website
- Andrew Storey
Abbvie
United States
VP
- Stacie Maass
American Pharmacist
United States
SVP Government Affairs
- Oved Amitay
Alnylam Pharma
United States
Vice President
...see the full speaker list on our website
EIN News
provides powerful, real-time media monitoring, news aggregation & syndication services. Read the latest news about this topic. See:
- Autism News Today
- Brain Cancer News Today
- Breast Cancer News Today
- Breastfeeding News Today
- Conferences & Trade Shows Today
- Dental Industry Today
- Dietary Supplements News Today
- H1N1 News Today
- H7N9 Bird Flu News Today
- Health Insurance Exchanges News
- Healthcare Industry Today
- Healthcare Reform News Today
- Home Birth News Today
- Lung Cancer News Today
- MERS News Today
- Malaria News Today
- Marijuana News Today
- Mesothelioma News Today
- Pharmaceutical Industry Today
- Planned Parenthood News Today
- Prostate Cancer News Today
- SARS News Today
- Wellness News Today